Somlo, G., Doroshow, J. H., Synold, T., Longmate, J., Reardon, D., Chow, W., . . . Alvarnas, J. (2001). High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: Toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome. Nature Publishing Group.
Chicago Style CitationSomlo, G., et al. High-dose Paclitaxel in Combination With Doxorubicin, Cyclophosphamide and Peripheral Blood Progenitor Cell Rescue in Patients With High-risk Primary and Responding Metastatic Breast Carcinoma: Toxicity Profile, Relationship to Paclitaxel Pharmacokinetics and Short-term Outcome. Nature Publishing Group, 2001.
Cita MLASomlo, G., et al. High-dose Paclitaxel in Combination With Doxorubicin, Cyclophosphamide and Peripheral Blood Progenitor Cell Rescue in Patients With High-risk Primary and Responding Metastatic Breast Carcinoma: Toxicity Profile, Relationship to Paclitaxel Pharmacokinetics and Short-term Outcome. Nature Publishing Group, 2001.